238 related articles for article (PubMed ID: 29705537)
21. KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Srinivasan S; Dhamne C; Patkar N; Chatterjee G; Moulik NR; Chichra A; Pallath A; Tembhare P; Shetty D; Subramanian PG; Narula G; Banavali S
Pediatr Blood Cancer; 2024 Feb; 71(2):e30791. PubMed ID: 38014874
[TBL] [Abstract][Full Text] [Related]
22. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-RUNX1T1 transcripts.
Sasaki K; Tsujimoto S; Miyake M; Uchiyama Y; Ikeda J; Yoshitomi M; Shimosato Y; Tokumasu M; Matsuo H; Yoshida K; Ohki K; Kaburagi T; Yamato G; Hara Y; Takeuchi M; Kinoshita A; Tomizawa D; Taga T; Adachi S; Tawa A; Horibe K; Hayashi Y; Matsumoto N; Ito S; Shiba N
Br J Haematol; 2021 Jul; 194(2):414-422. PubMed ID: 34120331
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia.
Park SH; Chi HS; Min SK; Park BG; Jang S; Park CJ
Leuk Res; 2011 Oct; 35(10):1376-83. PubMed ID: 21715005
[TBL] [Abstract][Full Text] [Related]
24. Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center.
Duan W; Liu X; Zhao X; Jia J; Wang J; Gong L; Jiang Q; Zhao T; Wang Y; Zhang X; Xu L; Shi H; Chang Y; Liu K; Huang X; Qin Y; Jiang H
Ann Hematol; 2021 May; 100(5):1203-1212. PubMed ID: 33474629
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia].
Wu TM; Xue SL; Li Z; Yu JQ; Wang J; Wang BR; Wan CL; Shen XD; Qiu QC; Bao XB; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):646-653. PubMed ID: 34547870
[No Abstract] [Full Text] [Related]
26. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia.
Itzykson R; Duployez N; Fasan A; Decool G; Marceau-Renaut A; Meggendorfer M; Jourdan E; Petit A; Lapillonne H; Micol JB; Cornillet-Lefebvre P; Ifrah N; Leverger G; Dombret H; Boissel N; Haferlach T; Preudhomme C
Blood; 2018 Jul; 132(2):187-196. PubMed ID: 29692343
[TBL] [Abstract][Full Text] [Related]
27. Integrative analysis of prognostic factors in Chinese core binding factor leukemia.
Wang D; Qiao C; Xiao M; Geng Z; Shang Z; He J; Huang M; Yang Y; Zhang N; Liu Y; Li J; Li C; Zhou J
Biochem Biophys Res Commun; 2012 Nov; 428(3):411-5. PubMed ID: 23107788
[TBL] [Abstract][Full Text] [Related]
28. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia.
Hsiao HH; Liu YC; Wang HC; Tsai YF; Wu CH; Cho SF; Hsu JF; Huang CT; Hsiao SY; Lee CP; Chang CS; Lin SF; Liu TC
Genet Mol Res; 2015 Dec; 14(4):17028-33. PubMed ID: 26681050
[TBL] [Abstract][Full Text] [Related]
29. Detection of KIT and FLT3 mutations in acute myeloid leukemia with different subtypes.
Zaker F; Mohammadzadeh M; Mohammadi M
Arch Iran Med; 2010 Jan; 13(1):21-5. PubMed ID: 20039765
[TBL] [Abstract][Full Text] [Related]
30. Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients.
Akram AM; Hassan M; Chaudhary A; Hayat S; Ali Q; Hussain T; Zafar A; Javed MA
Sci Rep; 2022 Nov; 12(1):19252. PubMed ID: 36357474
[TBL] [Abstract][Full Text] [Related]
31. Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.
Wakita S; Yamaguchi H; Miyake K; Mitamura Y; Kosaka F; Dan K; Inokuchi K
Leukemia; 2011 Sep; 25(9):1423-32. PubMed ID: 21606963
[TBL] [Abstract][Full Text] [Related]
32. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia.
Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC
Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387
[TBL] [Abstract][Full Text] [Related]
33. Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome.
Cher CY; Leung GM; Au CH; Chan TL; Ma ES; Sim JP; Gill H; Lie AK; Liang R; Wong KF; Siu LL; Tsui CS; So CC; Wong HW; Yip SF; Lee HK; Liu HS; Lau JS; Luk TH; Lau CK; Lin SY; Kwong YL; Leung AY
Blood Cancer J; 2016 Jul; 6(7):e442. PubMed ID: 27391574
[TBL] [Abstract][Full Text] [Related]
34. KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
Beghini A; Ripamonti CB; Cairoli R; Cazzaniga G; Colapietro P; Elice F; Nadali G; Grillo G; Haas OA; Biondi A; Morra E; Larizza L
Haematologica; 2004 Aug; 89(8):920-5. PubMed ID: 15339674
[TBL] [Abstract][Full Text] [Related]
35. Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M; Murata C; Shimada A; Ohki K; Hayashi Y; Saito AM; Fujimoto J; Horibe K; Nagao M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Tomizawa D; Taga T; Tawa A; Tanaka S; Heike T; Adachi S
Leukemia; 2015 Dec; 29(12):2438-41. PubMed ID: 25975190
[No Abstract] [Full Text] [Related]
36. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study.
Cairoli R; Beghini A; Grillo G; Nadali G; Elice F; Ripamonti CB; Colapietro P; Nichelatti M; Pezzetti L; Lunghi M; Cuneo A; Viola A; Ferrara F; Lazzarino M; Rodeghiero F; Pizzolo G; Larizza L; Morra E
Blood; 2006 May; 107(9):3463-8. PubMed ID: 16384925
[TBL] [Abstract][Full Text] [Related]
37. KIT mutations confer a distinct gene expression signature in core binding factor leukaemia.
Lück SC; Russ AC; Du J; Gaidzik V; Schlenk RF; Pollack JR; Döhner K; Döhner H; Bullinger L
Br J Haematol; 2010 Mar; 148(6):925-37. PubMed ID: 20064158
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
Chen W; Xie H; Wang H; Chen L; Sun Y; Chen Z; Li Q
PLoS One; 2016; 11(1):e0146614. PubMed ID: 26771376
[TBL] [Abstract][Full Text] [Related]
39. [Genetic abnormalities in core binding factor acute myeloid leukemia].
Ishikawa Y
Rinsho Ketsueki; 2017; 58(8):991-998. PubMed ID: 28883285
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia.
Mao X; Yin R; Liu L; Zhou Y; Yang C; Fang C; Jiang H; Guo Q; Tian X
Pediatr Neonatol; 2023 Jul; 64(4):435-441. PubMed ID: 36809862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
